Pulse Biosciences Inc IPO year
What is the IPO year of Pulse Biosciences Inc?
The IPO year of Pulse Biosciences Inc is 2016
What is the definition of IPO year?
Initial public offering is a type of public offering in which shares of a company usually are sold to institutional investors that in turn, sell to the general public, on a securities exchange, for the first time.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
IPO year of companies in the Health Care sector on NASDAQ compared to Pulse Biosciences Inc
What does Pulse Biosciences Inc do?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Companies with ipo year similar to Pulse Biosciences Inc
- The Toronto-Dominion Bank PFD SER 9 3.7% has IPO year of 2015
- Fura Gems has IPO year of 2015
- Hostess Brands has IPO year of 2015
- Nabriva Therapeutics Plc has IPO year of 2015
- REF has IPO year of 2015
- H-Source has IPO year of 2015
- Pulse Biosciences Inc has IPO year of 2016
- American Pacific Borates has IPO year of 2017
- Razer has IPO year of 2017
- DEAG Deutsche Entertainment Aktiengesellschaft has IPO year of 2017
- Hamilton Beach Brands Co has IPO year of 2017
- Artelo Biosciences has IPO year of 2017
- VARTA AG has IPO year of 2017